These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 35771290)

  • 1. Reliability and Validity of the Repeatable Battery for Assessment of Neuropsychological Status Scale in Evaluation of Vascular Cognitive Impairment in Elderly Han Population.
    Zhang CY; Deng YM; Li DM; Shi QY; Yang XP; Zhao YH; Yang B; Song LG; Li X
    Noro Psikiyatr Ars; 2022; 59(2):147-150. PubMed ID: 35685057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Mild Cognitive Impairment Using CogEvo: A Computerized Cognitive Function Assessment Tool.
    Satoh T; Sawada Y; Saba H; Kitamoto H; Kato Y; Shiozuka Y; Kuwada T; Shima S; Murakami K; Sasaki M; Abe Y; Harano K
    J Prim Care Community Health; 2024; 15():21501319241239228. PubMed ID: 38504559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Repeatable Battery for the Assessment of Neuropsychological Status, While Useful for Measuring Cognitive Changes in Manifest Huntington Disease, May Show Limited Utility in Premanifest Disease.
    Mustafa AI; Corey-Bloom J; Beltran-Najera I; Snell C; Castleton J; Smith H; Gilbert PE
    Cogn Behav Neurol; 2022 Sep; 35(3):198-203. PubMed ID: 35830248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-Validating the Executive Errors Scale of the Repeatable Battery for the Assessment of Neuropsychological Status.
    Gradwohl BD; Hale AC; Spencer RJ
    Percept Mot Skills; 2023 Oct; 130(5):1970-1984. PubMed ID: 37380620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two cognitive screening measures in a longitudinal sample of youth at-risk for psychosis.
    Kantor JR; Gur RC; Calkins ME; Moore TM; Port AM; Ruparel K; Scott JC; Troyan S; Gur RE; Roalf DR
    Schizophr Res; 2022 Aug; 246():216-224. PubMed ID: 35809354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mini Mental State Examination does not accurately screen for objective cognitive impairment in Fabry Disease.
    Körver S; van de Schraaf SAJ; Geurtsen GJ; Hollak CEM; van Schaik IN; Langeveld M
    JIMD Rep; 2019 Jul; 48(1):53-59. PubMed ID: 31392113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compassion Versus Accuracy: Lenient Scoring of the Spatial Orientation Items on the Mini-mental State Exam Lowers Sensitivity.
    Kent K; Adly Ibrahim N; Romero K; Baker S; Greenacre M; Boucher CM; Roth RM; Erdodi LA
    Alzheimer Dis Assoc Disord; 2024 Jan-Mar 01; 38(1):98-100. PubMed ID: 38300875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kihito, a Traditional Japanese Kampo Medicine, Improves Cognitive Function in Alzheimer's Disease Patients.
    Watari H; Shimada Y; Matsui M; Tohda C
    Evid Based Complement Alternat Med; 2019; 2019():4086749. PubMed ID: 31217803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers.
    Levine AJ; Palomo M; Hinkin CH; Valdes-Sueiras M; Lopez E; Mathisen G; Donovan S; Singer EJ
    Neurobehav HIV Med; 2011; 3():79-86. PubMed ID: 26448691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telehealth group Cognitive-Behavioral Therapy for Insomnia (CBT-I) in primary brain tumor: Primary outcomes from a single-arm phase II feasibility and proof-of-concept trial.
    Loughan AR; Lanoye A; Willis KD; Fox A; Ravyts SG; Zukas A; Kim Y
    Neuro Oncol; 2024 Mar; 26(3):516-527. PubMed ID: 37796017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of cognitive performance in kidney transplant recipients: a mini review.
    Schietzel S; Kressig RW; Huynh-Do U
    Front Nephrol; 2023; 3():1238501. PubMed ID: 37780580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Utility of the TYM and RBANS in a One-Stop Memory Clinic in Singapore: A Pilot Study.
    Dong Y; Ling MTY; Ng KET; Wang A; Wan EYS; Merchant RA; Venketasubramanian N; Chen CL; Mahendran R; Collinson SL
    J Geriatr Psychiatry Neurol; 2019 Mar; 32(2):68-73. PubMed ID: 30630388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.
    Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A
    AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
    Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
    Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-examining popular screening measures in neuro-oncology: MMSE and RBANS.
    Aslanzadeh F; Braun S; Brechbiel J; Willis K; Parker K; Lanoye A; Loughan A
    Support Care Cancer; 2022 Oct; 30(10):8041-8049. PubMed ID: 35771290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-Mental State Examination: Optimal Cut-Off Levels for Mild and Severe Cognitive Impairment.
    Salis F; Costaggiu D; Mandas A
    Geriatrics (Basel); 2023 Jan; 8(1):. PubMed ID: 36648917
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.